GT BIOPHARMA INC
GTBP·36254L308·US·Common Stock·Healthcare - Biotechnology-13D/G
GTBP (GT BIOPHARMA INC) is held by 23 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($184,436), GEODE CAPITAL MANAGEMENT, LLC ($130,648), VANGUARD FIDUCIARY TRUST CO ($110,710). Net institutional sentiment: Mixed.
23
Holders
(2 Elite)
$608,528
Total Value
57% (23)
Consensus
13 buying - 10 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders none · Activists Jun 2, 2025 · Congress none
ActivistBIBristol Investment Fund, Ltd.2.4%Jun 2, 2025
ActivistFNFive Narrow Lane LP10.0%May 14, 2025
Top Holders
Checking access…
Showing 1-20 of 27
1 / 2
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer